Maryse Baia

MYC-IG rearrangements are negative predictors of survival in DLBCL patients treated with immunochemotherapy: a GELA/LYSA study

Christiane Copie‐Bergman, Peggy Cuillière-Dartigues, Maryse Baia et al. · Blood · 2015 · 254 citations · Full text

Life Sciences, Immunology, Oncology +12

Prognostic Significance of <i>MYC</i> Rearrangement and Translocation Partner in Diffuse Large B-Cell Lymphoma: A Study by the Lunenburg Lymphoma Biomarker Consortium

Andreas Rosenwald, Susanne Bens, Ranjana H. Advani et al. · Journal of Clinical Oncology · 2019 · 254 citations · Full text

Medicine, Hematology, Oncology +17

Human IL4I1 is a secreted l-phenylalanine oxidase expressed by mature dendritic cells that inhibits T-lymphocyte proliferation

Marie‐Laure Boulland, Jeanine Marquet, Valérie Molinier‐Frenkel et al. · Blood · 2007 · 204 citations · Full text

Life Sciences, Immunology, Cellular Immunology +10

Follicular lymphoma cell niche: identification of a preeminent IL-4-dependent TFH–B cell axis

Céline Pangault, Patricia Amé-Thomas, Philippe Ruminy et al. · Leukemia · 2010 · 133 citations · Full text

Life Sciences, Immunology, Oncology +12

Immuno–Fluorescence In Situ Hybridization Index Predicts Survival in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP: A GELA Study

Christiane Copie‐Bergman, Philippe Gaulard, Karen Leroy et al. · Journal of Clinical Oncology · 2009 · 125 citations

Medicine, Hematology, Oncology +16